Alopecia areata in pediatric patients is associated with increased rates of anxiety and depression, representing a significant psychiatric burden during adolescence.

From the articleBaricitinib Approved for Severe Alopecia Areata in Adolescents | AJMCAlso in FDA approves Olumiant for teens with severe alopecia